Salon Today
JUNE 12, 2024
In a challenge to see how much water they could save, ten salons lock up their traditional towels and adopt Scrummi disposable towels for one week. The result? They saved 2,500 gallons of water. See who won the challenge.
Alison Bladh
JUNE 12, 2024
I get asked all the time about collagen supplements and the foods that can help boost collagen production. Collagen, a crucial protein for skin, hair, nails, and joints, declines as we age. This natural decrease often leads to visible signs of ageing and joint discomfort, prompting many to seek ways to replenish their collagen levels. Here’s how to choose the best collagen supplement to support your overall health and well-being.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MedEsthetics
JUNE 12, 2024
Researchers at NYU Langone Health found that the interleukin-17 (IL-17) pathway, whose activity is blocked by existing anti-inflammatory drugs, activates a protein called hypoxia-inducible factor 1-alpha (HIF-1-alpha) in psoriasis.
Dermatology Times
JUNE 12, 2024
Researchers hypothesize that skin contact with e-cigarette fluids can trigger an inflammatory response.
Salon Today
JUNE 12, 2024
Consumers aren't the only ones that can fall victim to online scams, businesses are prey for scammers, too. An expert compiles a list of the top five common payment scams and how to avoid them.
Dermatology Times
JUNE 12, 2024
Conversely, there were higher levels of selenium and folic acid detected in patients with vitiligo versus otherwise healthy individuals.
Esthetician Leadership Today brings together the best content for skin care professionals from the widest variety of industry thought leaders.
Dermatology Times
JUNE 12, 2024
A recent review found that teledermatology could improve patient access, increase efficiency, and cut down on costly hospital admissions.
Lipgloss and Aftershave
JUNE 12, 2024
JET Plasma is the sensation that’s been sweeping the medical + spa skin care industry for the past three years. L+A first showcased JET Plasma PROFOSMA in March of 2022 and has enjoyed watching the L+A community fall in love with this device! L+A received notification from Aubrey at Pro Plasma Esthetic that they had a huge announcement to share with L+A about 2 ALL-NEW devices that Pro Plasma Esthetic plans to launch at the IECSC Las Vegas!
Dermatology Times
JUNE 12, 2024
The study found patients with vitiligo are at a lower risk of developing PD, but those with comorbid PD could face elevated mortality rates.
Beauty Launchpad
JUNE 12, 2024
Get to know Shelby Aldstadt (@paintitblonde). She is a hair artist at Golden Hour Hair Lounge in Huntington Beach, CA.
Dermatology Times
JUNE 12, 2024
Ahead of the next 3 months of the year, Dermatology Times wants to know what conferences and meetings you plan to attend between July and September. Share your thoughts with us by June 26.
National Laser Institute
JUNE 12, 2024
Are you a hospital nurse who is feeling burned out from bedside nursing? You are not alone. It’s a tough. Read more » The post Start Your New Practice With An Aesthetic Nursing Course appeared first on National Laser Institute.
Dermatology Times
JUNE 12, 2024
Dr. Elizabeth Kiracofe, MD, FAAD, and Dr. Jenny Murase, MD, introduce a discussion on the undertreatment of patients with atopic dermatitis, particularly focusing on pregnant individuals and those of childbearing age.
Beauty Launchpad
JUNE 12, 2024
Scruples Haircare part of the Beauty Elite Group and headquartered in Houston, Texas, continues its growth with a new partnership with Marlo Beauty Supply.
Dermatology Times
JUNE 12, 2024
Experts on atopic dermatitis discuss the importance of open dialogue with patients who are pregnant or of childbearing potential regarding the safety concerns associated with treatments for this condition.
The Dermatology Digest
JUNE 12, 2024
Evolus, Inc. is rolling out Nuceiva (botulinum toxin type A) across Spain. The product is now available for direct order and delivery to Spanish medical aesthetics healthcare professionals. Nuceiva is approved by the European Commission for the temporary improvement in the appearance of moderate to severe glabellar lines when the severity of the above facial lines has an important psychological impact in adults below 65 years of age.
Aesthetic Back Bar
JUNE 12, 2024
What should you consider when setting prices for your spa services and products? There is an array of costs you will need to review when it comes down to setting prices within your business. You do not want to set your pricing too low and undervalue your business. Ask yourself questions such as; what is your brand identity and who is your target demographic?
The Dermatology Digest
JUNE 12, 2024
LEADderm is a new dermatology conference that aims to empower dermatologists to build fulfilling careers, lead with purpose, and create inclusive communities. The first-ever LEADderm meeting was held at the Pendry Hotel in Newport Beach, CA, from May 31 through June 2, 2024. Here, Founder and Chair Jennifer Soung, MD, shares her inspiration for starting this meeting and highlights key sessions.
US Dermatologt Partners
JUNE 12, 2024
Shingles is a common condition that typically impacts adults aged 50 and over. If you’ve had chickenpox, you can develop shingles. According to Dr. Tamara Hill of U.S. Dermatology Partners in Granbury, Texas , “Shingles is a common and contagious viral infection. If you notice warning signs of shingles, you should notify your dermatologist right away.
The Dermatology Digest
JUNE 12, 2024
New research suggests that interleukin (IL)-12/23 and IL-23 inhibitors reduce the incidence of progression to psoriatic arthritis (PsA) among people with psoriasis when compared to tumor necrosis factor inhibitors (TNFi) and IL-17 inhibitors. The findings, which were presented at EULAR 2024 in Vienna, Austria, held in naïve and bio-experienced patients.
The Dermatology Digest
JUNE 12, 2024
Tralokinumab (Adtralza, Leo) 300 mg/2 mL is now available as a pre-filled pen in Canada. A human, monoclonal antibody targeting the interleukin (IL)-13 cytokine, tralokinumab is currently indicated in patients 12 and older with moderate-to-severe atopic dermatitis (AD) whose disease is not adequately controlled with topical prescription therapies or when those therapies are not advisable.
Expert insights. Personalized for you.
116 
Let's personalize your content